RNAi Technology Market by Therapeutics - Global Industry Analysis & Forecast to 2025

Published On : June 2019 Pages : 170 Category: Healthcare IT Report Code : HC064090

RNAi Technology Market by Therapeutics (Neurological Disorders, Hepatitis B and C, Oncology, Autoimmune Hepatitis, Other) - Global Industry Analysis & Forecast to 2025

Industry Outlook and Trend Analysis

The RNA interference (RNAi) is a biochemical procedure where RNA particles restrain quality gene or translation, by neutralizing targeted mRNA atoms. In RNAi innovation, double-stranded RNA silences the quality gene. This is by the inhibition of the interpretation procedure or by the corruption of mRNA. RNAi encourages cell protection from diseases happened by RNA infections, for example, flu infection and rhabdovirus. Transposons and infections are the objectives of RNAi innovation.

Drivers and Restraints

The broad utilization of RNAi innovation in the treatment of viral sicknesses, neurodegenerative diseases and oncology, is driving the development of RNAi innovation market. Malignancy, HIV, Parkinson's sickness, Respiratory syncytial infection, and Hepatitis are maladies treated by RNAi innovation. As indicated by WHO, in 2017, all around 940000 individuals kicked the bucket of HIV. Nations have a pledge to the destruction of infections, this making a heading for the development of RNAi innovation in the market.

Regional Insights

Among the geologies, North America dominates the market by holding a major offer in the market of RNAi technology.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Merck & Co., Inc
  • Arcturus Therapeutics Ltd
  • Quark Pharmaceuticals
  • Ionis Pharmaceuticals
  • Silence Therapeutics
  • Dicerna Pharmaceuticals
  • Thermo Fisher Scientific
  • Alnylam Pharmaceuticals Inc

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         RNAi Technology Market, By Therapeutics, Estimates and Forecast, 2014-2025 ($Million)

o    Neurological Disorders

o    Hepatitis B and C

o    Oncology

o    Autoimmune Hepatitis

o    Other

·         RNAi Technology Market, By Key Players

o    Merck & Co., Inc

o    Arcturus Therapeutics Ltd

o    Quark Pharmaceuticals

o    Ionis Pharmaceuticals

o    Silence Therapeutics

o    Dicerna Pharmaceuticals

o    Thermo Fisher Scientific

o    Alnylam Pharmaceuticals Inc

·         RNAi Technology Market, By Region, Estimates and Forecast, 2014-2025 ($Million)

o    North America

§  North America RNAi Technology Market, By Country

o    U.S. RNAi Technology Market

o    Canada RNAi Technology Market

o    Mexico RNAi Technology Market

o    Europe

§  Europe RNAi Technology Market, By Country

o    Germany RNAi Technology Market

o    UK RNAi Technology Market

o    France RNAi Technology Market

o    Russia RNAi Technology Market

o    Italy RNAi Technology Market

o    Rest of Europe RNAi Technology Market

o    Asia-Pacific

§  Asia-Pacific RNAi Technology Market, By Country

o    China RNAi Technology Market

o    Japan RNAi Technology Market

o    South Korea RNAi Technology Market

o    India RNAi Technology Market

o    Southeast Asia RNAi Technology Market

o    Rest of Asia-Pacific RNAi Technology Market

o    South America

§  South America RNAi Technology Market

o    Brazil RNAi Technology Market

o    Argentina RNAi Technology Market

o    Columbia RNAi Technology Market

o    Rest of South America RNAi Technology Market

o    Middle East and Africa

§  Middle East and Africa RNAi Technology Market

o    Saudi Arabia RNAi Technology Market

o    UAE RNAi Technology Market

o    Egypt RNAi Technology Market

o    Nigeria RNAi Technology Market

o    South Africa RNAi Technology Market

o    Rest of MEA RNAi Technology Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       RNAi Technology Market, By Therapeutics

5.1.     Introduction

5.2.     Global RNAi Technology Revenue and Market Share by Therapeutics (2014-2018)

5.2.1.  Global RNAi Technology Revenue and Revenue Share by Therapeutics (2014-2018)

5.3.     Neurological Disorders

5.3.1.  Global Neurological Disorders Revenue and Growth Rate (2014-2018)

5.4.     Hepatitis B and C

5.4.1.  Global Hepatitis B and C Revenue and Growth Rate (2014-2018)

5.5.     Oncology

5.5.1.  Global Oncology Revenue and Growth Rate (2014-2018)

5.6.     Autoimmune Hepatitis

5.6.1.  Global Autoimmune Hepatitis Revenue and Growth Rate (2014-2018)

5.7.     Other

5.7.1.  Global Other Revenue and Growth Rate (2014-2018)

6.       RNAi Technology Market, By Region

6.1.     Introduction

6.2.     Global RNAi Technology Revenue and Market Share by Regions

6.2.1.  Global RNAi Technology Revenue by Regions (2014-2018)

6.3.     North America RNAi Technology by Countries

6.3.1.  North America RNAi Technology Revenue and Growth Rate (2014-2018)

6.3.2.  North America RNAi Technology Revenue (Million USD) by Countries (2014-2018)

6.3.3.  United States

6.3.3.1.  United States RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.3.4.  Canada

6.3.4.1.  Canada RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.3.5.  Mexico

6.3.5.1.  Mexico RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.     Europe RNAi Technology by Countries

6.4.1.  Europe RNAi Technology Revenue and Growth Rate (2014-2018)

6.4.2.  Europe RNAi Technology Revenue (Million USD) by Countries (2014-2018)

6.4.3.  Germany

6.4.3.1.  Germany RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.4.  France

6.4.4.1.  France RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.5.  UK

6.4.5.1.  UK RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.6.  Russia

6.4.6.1.  Russia RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.7.  Italy

6.4.7.1.  Italy RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.8.  Rest of Europe

6.4.8.1.  Rest of Europe RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.     Asia-Pacific RNAi Technology by Countries

6.5.1.  Asia-Pacific RNAi Technology Revenue and Growth Rate (2014-2018)

6.5.2.  Asia-Pacific RNAi Technology Revenue (Million USD) by Countries (2014-2018)

6.5.3.  China

6.5.3.1.  China RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.4.  Japan

6.5.4.1.  Japan RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.5.  Korea

6.5.5.1.  Korea RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.6.  India

6.5.6.1.  India RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.7.  Southeast Asia

6.5.7.1.  Southeast Asia RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.8.  Rest of Asia-Pacific

6.5.8.1.  Rest of Asia-Pacific RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.6.     South America RNAi Technology by Countries

6.6.1.  South America RNAi Technology Revenue and Growth Rate (2014-2018)

6.6.2.  South America RNAi Technology Revenue (Million USD) by Countries (2014-2018)

6.6.3.  Brazil

6.6.3.1.  Brazil RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.6.4.  Argentina

6.6.4.1.  Argentina RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.6.5.  Columbia

6.6.5.1.  Columbia RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.6.6.  Rest of South America

6.6.6.1.  Rest of South America RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.     Middle East and Africa RNAi Technology by Countries

6.7.1.  Middle East and Africa RNAi Technology Revenue and Growth Rate (2014-2018)

6.7.2.  Middle East and Africa RNAi Technology Revenue (Million USD) by Countries (2014-2018)

6.7.3.  Saudi Arabia

6.7.3.1.  Saudi Arabia RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.4.  United Arab Emirates

6.7.4.1.  United Arab Emirates RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.5.  Egypt

6.7.5.1.  Egypt RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.6.  Nigeria

6.7.6.1.  Nigeria RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.7.  South Africa

6.7.7.1.  South Africa RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.8.  Turkey

6.7.8.1.  Turkey RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.9.  Rest of Middle East and Africa

6.7.9.1.  Rest of Middle East and Africa RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)

7.       Company Profiles

7.1.     Merck & Co., Inc

7.1.1.  Business Overview

7.1.2.   Service Portfolio

7.1.3.  Strategic Developments

7.1.4.  Financial Overview

7.2.     Arcturus Therapeutics Ltd

7.2.1.  Business Overview

7.2.2.   Service Portfolio

7.2.3.  Strategic Developments

7.2.4.  Financial Overview

7.3.     Quark Pharmaceuticals

7.3.1.  Business Overview

7.3.2.   Service Portfolio

7.3.3.  Strategic Developments

7.3.4.  Financial Overview

7.4.     Ionis Pharmaceuticals

7.4.1.  Business Overview

7.4.2.   Service Portfolio

7.4.3.  Strategic Developments

7.4.4.  Financial Overview

7.5.     Silence Therapeutics

7.5.1.  Business Overview

7.5.2.   Service Portfolio

7.5.3.  Strategic Developments

7.5.4.  Financial Overview

7.6.     Dicerna Pharmaceuticals

7.6.1.  Business Overview

7.6.2.   Service Portfolio

7.6.3.  Strategic Developments

7.6.4.  Financial Overview

7.7.     Thermo Fisher Scientific

7.7.1.  Business Overview

7.7.2.   Service Portfolio

7.7.3.  Strategic Developments

7.7.4.  Financial Overview

7.8.     Alnylam Pharmaceuticals Inc

7.8.1.  Business Overview

7.8.2.   Service Portfolio

7.8.3.  Strategic Developments

7.8.4.  Financial Overview

8.       RNAi Technology Market Forecast (2018-2025)

8.1.     Global RNAi Technology Revenue (Millions USD) and Growth Rate (2018-2025)

8.2.     RNAi Technology Market Forecast by Regions (2018-2025)

8.2.1.  North America RNAi Technology Market Forecast (2018-2025)

8.2.1.1.  United States RNAi Technology Market Forecast (2018-2025)

8.2.1.2.  Canada RNAi Technology Market Forecast (2018-2025)

8.2.1.3.  Mexico RNAi Technology Market Forecast (2018-2025)

8.2.2.  Europe RNAi Technology Market Forecast (2018-2025)

8.2.2.1.  Germany RNAi Technology Market Forecast (2018-2025)

8.2.2.2.  France RNAi Technology Market Forecast (2018-2025)

8.2.2.3.  UK RNAi Technology Market Forecast (2018-2025)

8.2.2.4.  Russia RNAi Technology Market Forecast (2018-2025)

8.2.2.5.  Italy RNAi Technology Market Forecast (2018-2025)

8.2.2.6.  Rest of Europe RNAi Technology Market Forecast (2018-2025)

8.2.3.  Asia-Pacific RNAi Technology Market Forecast (2018-2025)

8.2.3.1.  China RNAi Technology Market Forecast (2018-2025)

8.2.3.2.  Japan RNAi Technology Market Forecast (2018-2025)

8.2.3.3.  Korea RNAi Technology Market Forecast (2018-2025)

8.2.3.4.  India RNAi Technology Market Forecast (2018-2025)

8.2.3.5.  Southeast Asia RNAi Technology Market Forecast (2018-2025)

8.2.3.6.  Rest of Asia-Pacific RNAi Technology Market Forecast (2018-2025)

8.2.4.  South America RNAi Technology Market Forecast (2018-2025)

8.2.4.1.  Brazil RNAi Technology Market Forecast (2018-2025)

8.2.4.2.  Argentina RNAi Technology Market Forecast (2018-2025)

8.2.4.3.  Columbia RNAi Technology Market Forecast (2018-2025)

8.2.4.4.  Rest of South America RNAi Technology Market Forecast (2018-2025)

8.2.5.  Middle East and Africa RNAi Technology Market Forecast (2018-2025)

8.2.5.1.  Saudi Arabia RNAi Technology Market Forecast (2018-2025)

8.2.5.2.  United Arab Emirates RNAi Technology Market Forecast (2018-2025)

8.2.5.3.  Egypt RNAi Technology Market Forecast (2018-2025)

8.2.5.4.  Nigeria RNAi Technology Market Forecast (2018-2025)

8.2.5.5.  South Africa RNAi Technology Market Forecast (2018-2025)

8.2.5.6.  Turkey RNAi Technology Market Forecast (2018-2025)

8.2.5.7.  Rest of Middle East and Africa RNAi Technology Market Forecast (2018-2025)

8.3.     RNAi Technology Market Forecast by Therapeutics (2018-2025)

8.3.1.  RNAi Technology Forecast by Therapeutics (2018-2025)

8.3.2.  RNAi Technology Market Share Forecast by Therapeutics (2018-2025)


List of Tables

List of Tables and Figures:

Figure United States RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure France RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Europe RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure China RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure Korea RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure India RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Asia-Pacific RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure Brazil RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure Argentina RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure Columbia RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of South America RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure Saudi Arabia RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure United Arab Emirates RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure Egypt RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure Nigeria RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure South Africa RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure Turkey RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Middle East and Africa RNAi Technology Revenue (Million USD) and Growth Rate (2014-2025)
Table Global RNAi Technology Revenue and Revenue Share by Therapeutics (2014-2018)
Figure Global Neurological Disorders Revenue and Growth Rate (2014-2018)
Figure Global Hepatitis B and C Revenue and Growth Rate (2014-2018)
Figure Global Oncology Revenue and Growth Rate (2014-2018)
Figure Global Autoimmune Hepatitis Revenue and Growth Rate (2014-2018)
Figure Global Other Revenue and Growth Rate (2014-2018)
Table Global RNAi Technology Revenue by Regions (2014-2018)
Figure North America RNAi Technology Growth Rate (2014-2018)
Figure North America RNAi Technology Revenue and Growth Rate (2014-2018)
Figure North America RNAi Technology by Countries (2014-2018)
Figure North America RNAi Technology Revenue (Million USD) by Countries (2014-2018)
Figure United States RNAi Technology Growth Rate (2014-2018)
Figure United States RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Canada RNAi Technology Growth Rate (2014-2018)
Figure Canada RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Mexico RNAi Technology Growth Rate (2014-2018)
Figure Mexico RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Europe RNAi Technology Growth Rate (2014-2018)
Figure Europe RNAi Technology Revenue and Growth Rate (2014-2018)
Figure Europe RNAi Technology by Countries (2014-2018)
Figure Europe RNAi Technology Revenue (Million USD) by Countries (2014-2018)
Figure Germany RNAi Technology Growth Rate (2014-2018)
Figure Germany RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure France RNAi Technology Growth Rate (2014-2018)
Figure France RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure UK RNAi Technology Growth Rate (2014-2018)
Figure UK RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Russia RNAi Technology Growth Rate (2014-2018)
Figure Russia RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Italy RNAi Technology Growth Rate (2014-2018)
Figure Italy RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Europe RNAi Technology Growth Rate (2014-2018)
Figure Rest of Europe RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Asia-Pacific RNAi Technology Growth Rate (2014-2018)
Figure Asia-Pacific RNAi Technology Revenue and Growth Rate (2014-2018)
Figure Asia-Pacific RNAi Technology by Countries (2014-2018)
Figure Asia-Pacific RNAi Technology Revenue (Million USD) by Countries (2014-2018)
Figure China RNAi Technology Growth Rate (2014-2018)
Figure China RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Japan RNAi Technology Growth Rate (2014-2018)
Figure Japan RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Korea RNAi Technology Growth Rate (2014-2018)
Figure Korea RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure India RNAi Technology Growth Rate (2014-2018)
Figure India RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Southeast Asia RNAi Technology Growth Rate (2014-2018)
Figure Southeast Asia RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Asia-Pacific RNAi Technology Growth Rate (2014-2018)
Figure Rest of Asia-Pacific RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South America RNAi Technology Growth Rate (2014-2018)
Figure South America RNAi Technology Revenue and Growth Rate (2014-2018)
Figure South America RNAi Technology by Countries (2014-2018)
Figure South America RNAi Technology Revenue (Million USD) by Countries (2014-2018)
Figure Brazil RNAi Technology Growth Rate (2014-2018)
Figure Brazil RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Argentina RNAi Technology Growth Rate (2014-2018)
Figure Argentina RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Columbia RNAi Technology Growth Rate (2014-2018)
Figure Columbia RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of South America RNAi Technology Growth Rate (2014-2018)
Figure Rest of South America RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Middle East and Africa RNAi Technology Growth Rate (2014-2018)
Figure Middle East and Africa RNAi Technology Revenue and Growth Rate (2014-2018)
Figure Middle East and Africa RNAi Technology by Countries (2014-2018)
Figure Middle East and Africa RNAi Technology Revenue (Million USD) by Countries (2014-2018)
Figure Saudi Arabia RNAi Technology Growth Rate (2014-2018)
Figure Saudi Arabia RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure United Arab Emirates RNAi Technology Growth Rate (2014-2018)
Figure United Arab Emirates RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Egypt RNAi Technology Growth Rate (2014-2018)
Figure Egypt RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Nigeria RNAi Technology Growth Rate (2014-2018)
Figure Nigeria RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South Africa RNAi Technology Growth Rate (2014-2018)
Figure South Africa RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Turkey RNAi Technology Growth Rate (2014-2018)
Figure Turkey RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Middle East and Africa RNAi Technology Growth Rate (2014-2018)
Figure Rest of Middle East and Africa RNAi Technology Revenue (Millions USD) and Growth Rate (2014-2018)
Table Merck & Co., Inc RNAi Technology Financial Overview
Table Arcturus Therapeutics Ltd RNAi Technology Financial Overview
Table Quark Pharmaceuticals RNAi Technology Financial Overview
Table Ionis Pharmaceuticals RNAi Technology Financial Overview
Table Silence Therapeutics RNAi Technology Financial Overview
Table Dicerna Pharmaceuticals RNAi Technology Financial Overview
Table Thermo Fisher Scientific RNAi Technology Financial Overview
Table Alnylam Pharmaceuticals Inc RNAi Technology Financial Overview
Figure Global RNAi Technology Revenue (Millions USD) and Growth Rate (2018-2025)
Table RNAi Technology Market Forecast by Regions (2018-2025)
Figure North America RNAi Technology Market Forecast (2018-2025)
Figure United States RNAi Technology Market Forecast (2018-2025)
Figure Canada RNAi Technology Market Forecast (2018-2025)
Figure Mexico RNAi Technology Market Forecast (2018-2025)
Figure Europe RNAi Technology Market Forecast (2018-2025)
Figure Germany RNAi Technology Market Forecast (2018-2025)
Figure France RNAi Technology Market Forecast (2018-2025)
Figure UK RNAi Technology Market Forecast (2018-2025)
Figure Russia RNAi Technology Market Forecast (2018-2025)
Figure Italy RNAi Technology Market Forecast (2018-2025)
Figure Rest of Europe RNAi Technology Market Forecast (2018-2025)
Figure Asia-Pacific RNAi Technology Market Forecast (2018-2025)
Figure China RNAi Technology Market Forecast (2018-2025)
Figure Japan RNAi Technology Market Forecast (2018-2025)
Figure Korea RNAi Technology Market Forecast (2018-2025)
Figure India RNAi Technology Market Forecast (2018-2025)
Figure Southeast Asia RNAi Technology Market Forecast (2018-2025)
Figure Rest of Asia-Pacific RNAi Technology Market Forecast (2018-2025)
Figure South America RNAi Technology Market Forecast (2018-2025)
Figure Brazil RNAi Technology Market Forecast (2018-2025)
Figure Argentina RNAi Technology Market Forecast (2018-2025)
Figure Columbia RNAi Technology Market Forecast (2018-2025)
Figure Rest of South America RNAi Technology Market Forecast (2018-2025)
Figure Middle East and Africa RNAi Technology Market Forecast (2018-2025)
Figure Saudi Arabia RNAi Technology Market Forecast (2018-2025)
Figure United Arab Emirates RNAi Technology Market Forecast (2018-2025)
Figure Egypt RNAi Technology Market Forecast (2018-2025)
Figure Nigeria RNAi Technology Market Forecast (2018-2025)
Figure South Africa RNAi Technology Market Forecast (2018-2025)
Figure Turkey RNAi Technology Market Forecast (2018-2025)
Figure Rest of Middle East and Africa RNAi Technology Market Forecast (2018-2025)
Figure Global RNAi Technology Forecast by Therapeutics (2018-2025)
Figure Global RNAi Technology Market Share Forecast by Therapeutics (2018-2025)
Figure Global RNAi Technology Forecast by Therapeutics (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*